These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 25547703)

  • 1. [Risk factors and management of systemic reactions induced by subcutaneous immunotherapy].
    Wen L; Wen Z; Yang N
    Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):3001-4. PubMed ID: 25547703
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors of systemic allergic reactions caused by subcutaneous allergen immunotherapy].
    Li LS; Guan K; Yin J; Wang LL; Zhi YX; Sun JL; Li H; Wen LP; Tang R; Gu JQ; Wang ZX; Cui L; Xu YY; Bian SN
    Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Dec; 57(12):1972-1977. PubMed ID: 38186144
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic and large local reactions during subcutaneous grass pollen immunotherapy in children.
    Gur Cetinkaya P; Kahveci M; Esenboğa S; Karaatmaca B; Soyer O; Sekerel BE; Tuncer A; Sahiner UM
    Pediatr Allergy Immunol; 2020 Aug; 31(6):643-650. PubMed ID: 32320504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of risk factors for systemic adverse reactions to SCIT with natural depot allergen extracts: a retrospective study.
    Asero R
    Eur Ann Allergy Clin Immunol; 2015 Nov; 47(6):211-7. PubMed ID: 26549339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunologic effect and tolerability of intra-seasonal subcutaneous immunotherapy with an 8-day up-dosing schedule to 10,000 standardized quality-units: a double-blind, randomized, placebo-controlled trial.
    Pfaar O; Wolf H; Klimek L; Schnitker J; Wüstenberg E
    Clin Ther; 2012 Oct; 34(10):2072-81. PubMed ID: 23063373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local and systemic reactions to subcutaneous allergen immunotherapy: Ten years' experience in a pediatric clinic.
    Nacaroglu HT; Erdem SB; Sumer O; Karaman S; Unsal Karkıner CS; Asilsoy S; Gunay I; Can D
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):349-53. PubMed ID: 26905639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for fatal and nonfatal reactions to subcutaneous immunotherapy: National surveillance study on allergen immunotherapy (2008-2013).
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    Ann Allergy Asthma Immunol; 2016 Apr; 116(4):354-359.e2. PubMed ID: 26948485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Observation of systemic adverse reactions by specific immunotherapy and analysis of risk factors in allergic rhinitis].
    Shen Y; Hong SL; Zhang M; Ke X
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):801-805. PubMed ID: 29141287
    [No Abstract]   [Full Text] [Related]  

  • 9. Characterisation of systemic reactions to subcutaneous immunotherapy with airborne allergens and classification according to WAO 2010.
    Santos N; Pereira AM; Silva R; Torres da Costa J; Plácido JL
    Allergol Immunopathol (Madr); 2015; 43(1):25-31. PubMed ID: 24661594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions.
    Epstein TG; Liss GM; Murphy-Berendts K; Bernstein DI
    J Allergy Clin Immunol Pract; 2014; 2(2):161-7. PubMed ID: 24607043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diurnal variations in subcutaneous allergen immunotherapy reactions.
    Bavishi AA; Grammer LC; Pongracic J; Rychlik K; Kumar R; Zee P; Greenberger PA; Fishbein AB
    Ann Allergy Asthma Immunol; 2017 Jan; 118(1):103-107. PubMed ID: 27864091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are large local reactions a marker for systemic reactions to subcutaneous immunotherapy in children?
    Simsek IE; Aydogan M
    Asian Pac J Allergy Immunol; 2022 Mar; 40(1):75-80. PubMed ID: 34246207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety of subcutaneous immunotherapy with inhalant allergen extracts: a single-center 30-year experience from Turkey.
    Kartal O; Gulec M; Caliskaner Z; Musabak U; Sener O
    Immunopharmacol Immunotoxicol; 2015 Jun; 37(3):280-6. PubMed ID: 25858053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of systemic allergic reactions to allergen immunotherapy in a pediatric allergy clinic in Turkey.
    Bahceci Erdem S; Nacaroglu HT; Karaman S; Unsal Karkıner CS; Gunay I; Dogan D; Asilsoy S; Altınoz S; Can D
    Int J Pediatr Otorhinolaryngol; 2016 May; 84():55-60. PubMed ID: 27063754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of adverse reactions due to subcutaneous allergen immunotherapy applied between 2011-2021: Single center experience.
    Vural Solak GT; Aksu K; Solak Y; Demir Ş; Çuhadar Erçelebi D; Köycü Buhari G; Nazik Bahçecioğlu S; Koca Kalkan İ; Ateş H; Yeşilkaya S
    Tuberk Toraks; 2023 Dec; 71(4):356-366. PubMed ID: 38152006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is faster safer? Cluster versus short conventional subcutaneous allergen immunotherapy.
    Quiralte J; Justicia JL; Cardona V; Dávila I; Moreno E; Ruiz B; García MA
    Immunotherapy; 2013 Dec; 5(12):1295-303. PubMed ID: 24283840
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single centre retrospective study of systemic reactions to subcutaneous immunotherapy.
    Robertson K; Montazeri N; Shelke U; Jeimy S; Kim H
    Allergy Asthma Clin Immunol; 2020 Nov; 16(1):93. PubMed ID: 33292437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant allergen-based monitoring of antibody responses during injection grass pollen immunotherapy and after 5 years of discontinuation.
    Gadermaier E; Staikuniene J; Scheiblhofer S; Thalhamer J; Kundi M; Westritschnig K; Swoboda I; Flicker S; Valenta R
    Allergy; 2011 Sep; 66(9):1174-82. PubMed ID: 21480924
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of the antibody responses induced by subcutaneous injection immunotherapy with birch and Fagales pollen extracts adsorbed onto aluminum hydroxide.
    Gadermaier E; Flicker S; Aberer W; Egger C; Reider N; Focke M; Vrtala S; Kundi M; Valenta R
    Int Arch Allergy Immunol; 2010; 151(1):17-27. PubMed ID: 19672093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Short-term subcutaneous grass pollen immunotherapy under the umbrella of anti-IL-4: A randomized controlled trial.
    Chaker AM; Shamji MH; Dumitru FA; Calderon MA; Scadding GW; Makatsori M; Jones I; He QA; Subramanian KK; Arm JP; Durham SR; Schmidt-Weber CB
    J Allergy Clin Immunol; 2016 Feb; 137(2):452-461.e9. PubMed ID: 26531865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.